Filing Details
- Accession Number:
- 0001127602-11-010718
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-18 16:25:30
- Reporting Period:
- 2011-03-18
- Filing Date:
- 2011-03-18
- Accepted Time:
- 2011-03-18 16:25:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882796 | Biocryst Pharmaceuticals Inc | BCRX | Biological Products, (No Disgnostic Substances) (2836) | 621413174 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1385496 | P Jon Stonehouse | 2190 Parkway Lake Drive Birmingham AL 35244- | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-03-18 | 10,000 | $3.40 | 194,180 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Purchase was made in compliance with SEC rule 10b-18
Billionaire Hedge Funds
